"Mobile Stroke-Unit" for Reduction of the Response Time in Ischemic Stroke "MSU"


Phase N/A Results N/A

Summary of Purpose

Stroke, the most common cause of permanent disability, the second most common cause of dementia and third most common cause of death, has tremendous socio-economic consequences. Currently, systemic thrombolysis with the tissue plasminogen activator represents the only causal and approved treatment for acute ischemic stroke. However, the chances to save the brain tissue by a thrombolytic therapy exponentially...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 31 May 2015.

1 Nov 2008 13 Nov 2008 1 Jul 2011 1 Jul 2011 1 May 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Health Services Research
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment